Polaryx Therapeutics, Inc.(PLYX)
$1.60-0.07 (-4.19%)
PLYX
Polaryx Therapeutics, Inc. ownership
$1.60
At close:-0.07 (-4.19%)
Polaryx Therapeutics, Inc. (PLYX) Ownership - Who Owns Polaryx Therapeutics, Inc.?
24 Followers
Polaryx Therapeutics, Inc. (PLYX) Ownership Overview
- 49.07% Insiders
- 3.59% Mutual Funds
- 0.08% Other Institutional Investors
- 2.60% ETFs
- 44.65% Public Companies and Individual Investors
The ownership structure of Polaryx Therapeutics, Inc. (PLYX) stock is a mix of institutional, retail, and individual investors. Approximately 6.27% of the company’s stock is owned by Institutional Investors, 49.07% is owned by Insiders, and 44.65% is owned by Public Companies and Individual Investors.
The ownership structure of Polaryx Therapeutics, Inc. (PLYX) stock is a mix of institutional, retail, and individual investors. Approximately 6.27% of the company’s stock is owned by Institutional Investors, 49.07% is owned by Insiders, and 44.65% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 27, 2026 | Alex Keun Mo Yang | $360,004 | |
| Feb 19, 2026 | Michael Landis | $7,970 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Alex Keun Mo Yang | 24,233,249 | Insider | 48.62% | 38,773,198 |
| Vanguard Index Funds | 1,610,047 | Institution | 3.23% | 2,576,075 |
| Vanguard | 1,296,839 | Institution | 2.60% | 2,074,942 |
| Michael Landis | 228,225 | Insider | 0.46% | 365,160 |
| Fidelity Concord Street Trust | 130,217 | Institution | 0.26% | 208,347 |
| BlackRock, Inc. | 41,012 | Institution | 0.08% | 65,619 |
| Vanguard Valley Forge Funds | 25,969 | Institution | 0.05% | 41,550 |
| Vanguard Institutional Index Funds | 21,856 | Institution | 0.04% | 34,970 |
| John Hancock Variable Insurance Trust | 865 | Institution | <0.01% | 1,384 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,610,047 | Institution | 3.23% | 2,576,075 |
| Fidelity Concord Street Trust | 130,217 | Institution | 0.26% | 208,347 |
| Vanguard Valley Forge Funds | 25,969 | Institution | 0.05% | 41,550 |
| Vanguard Institutional Index Funds | 21,856 | Institution | 0.04% | 34,970 |
| John Hancock Variable Insurance Trust | 865 | Institution | <0.01% | 1,384 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total Stock Market ETF, VTI ETF | 1,156,845 | Institution | 2.32% | 2,024,479 |
| Vanguard Extended Market ETF, VXF ETF | 139,994 | Institution | 0.28% | 244,990 |
FAQ
Who Owns Polaryx Therapeutics, Inc. (PLYX)?
According to the latest TipRanks data, approximately 6.27% of the company's stock is held by institutional investors, 49.07% is held by insiders, and 44.65% is held by public companies and individual investors.
What percentage of Polaryx Therapeutics, Inc. (PLYX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.27% of Polaryx Therapeutics, Inc. (PLYX) stock is held by institutional investors: 3.59% by mutual funds, 2.60% by ETFs and 0.08% by other institutional investors.
What percentage of Polaryx Therapeutics, Inc. (PLYX) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.65% of Polaryx Therapeutics, Inc. (PLYX) stock is held by public companies and individual investors.
Who owns the most shares of Polaryx Therapeutics, Inc. (PLYX)?
Alex Keun Mo Yang owns the most shares of Polaryx Therapeutics, Inc. (PLYX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

